Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.79%39.39B | 2.33%39.37B | 0.35%149.72B | -0.73%37.45B | 0.42%36.56B | 1.80%37.24B | -0.03%38.47B | -4.94%149.19B | -3.56%37.72B | -4.67%36.41B |
Cost of revenue | 5.91%25.29B | 3.94%25.51B | 0.16%95.77B | -3.42%23.68B | 1.60%23.68B | 2.52%23.88B | 0.12%24.54B | -7.71%95.62B | -6.85%24.51B | -7.06%23.31B |
Gross profit | 5.58%14.11B | -0.50%13.86B | 0.70%53.94B | 4.26%13.77B | -1.66%12.88B | 0.53%13.36B | -0.30%13.93B | 0.46%53.57B | 3.20%13.21B | -0.08%13.1B |
Operating expense | 6.73%13.13B | 4.35%13.01B | 3.45%49.83B | 4.29%12.79B | 1.09%12.27B | 3.61%12.3B | 4.83%12.47B | 2.40%48.17B | 0.27%12.27B | 4.41%12.14B |
Staff costs | ---- | ---- | 3.92%22.5B | ---- | ---- | ---- | ---- | 3.04%21.65B | ---- | ---- |
Selling and administrative expenses | ---- | ---- | -2.62%4.34B | ---- | ---- | ---- | ---- | -7.82%4.46B | ---- | ---- |
-Selling and marketing expense | ---- | ---- | 2.34%1.88B | ---- | ---- | ---- | ---- | -34.39%1.84B | ---- | ---- |
-General and administrative expense | ---- | ---- | -6.10%2.46B | ---- | ---- | ---- | ---- | 28.64%2.62B | ---- | ---- |
Depreciation and amortization | ---- | ---- | 8.69%3.27B | ---- | ---- | ---- | ---- | 11.54%3.01B | ---- | ---- |
-Depreciation | ---- | ---- | 8.66%3.16B | ---- | ---- | ---- | ---- | 11.96%2.91B | ---- | ---- |
-Amortization | ---- | ---- | 9.57%103M | ---- | ---- | ---- | ---- | 0.00%94M | ---- | ---- |
Rent and land expenses | ---- | ---- | 1.66%9.7B | ---- | ---- | ---- | ---- | 2.56%9.54B | ---- | ---- |
Other operating expenses | ---- | ---- | 5.37%10.02B | ---- | ---- | ---- | ---- | 3.49%9.51B | ---- | ---- |
Operating profit | -7.82%978M | -41.92%848M | -23.86%4.11B | 3.83%975M | -36.20%615M | -25.23%1.06B | -29.71%1.46B | -14.12%5.4B | 67.08%939M | -35.22%964M |
Net non-operating interest income (expenses) | -135.71%-33M | -128.57%-32M | -33.96%-71M | -75.00%-21M | -69.23%-22M | 0.00%-14M | 0.00%-14M | 23.19%-53M | 20.00%-12M | 18.75%-13M |
Non-operating interest income | 16.67%7M | -16.67%5M | -19.35%25M | 0.00%7M | -25.00%6M | -25.00%6M | -25.00%6M | -6.06%31M | -12.50%7M | -11.11%8M |
Non-operating interest expense | 100.00%40M | 85.00%37M | 14.29%96M | 47.37%28M | 33.33%28M | -9.09%20M | -9.09%20M | -17.65%84M | -17.39%19M | -16.00%21M |
Net investment income | 31M | -7M | 42.42%-19M | -220.00%-6M | 25.00%-3M | -1,550.00%-33M | 400.00%5M | 0.00%-4M | ||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -200.00%-1M | 2,033.33%58M | 0 | 97.67%-1M | 3M | 1M | -3M | -43M | -43M | 0 |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -1,133.33%-74M | -5,333.33%-157M | -26.85%-978M | -139.21%-909M | -214.29%-66M | -121.43%-6M | 100.75%3M | -59.96%-771M | 24.60%-380M | -290.91%-21M |
Less:Restructuring and mergern&acquisition | --55M | --11M | --14M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Less:Other special charges | 83.33%11M | 166.67%2M | -71.07%81M | 700.00%16M | -70.48%62M | -81.25%6M | -108.33%-3M | 1,033.33%280M | 300.00%2M | 2,009.09%210M |
Less:Write off | --8M | --144M | 79.84%883M | 132.54%879M | 110.53%4M | --0 | --0 | -4.10%491M | -25.15%378M | ---38M |
Other non-operating income (expenses) | 9.09%156M | -42.86%96M | -1.80%599M | -18.68%148M | 1.45%140M | 3.62%143M | 10.53%168M | -3.33%610M | 13.04%182M | -16.87%138M |
Income before tax | -10.29%1.06B | -50.03%806M | -28.74%3.64B | -73.87%179M | -37.31%667M | -24.90%1.18B | -9.69%1.61B | -19.78%5.1B | 242.50%685M | -35.28%1.06B |
Income tax | -6.19%394M | -61.10%212M | -44.63%1.31B | -92.41%57M | -30.12%283M | -26.44%420M | -13.49%545M | 7.63%2.36B | 8,444.44%751M | -37.01%405M |
Net income | -12.57%661M | -44.42%593M | -15.06%2.33B | 286.36%123M | -41.64%384M | -24.10%756M | -7.62%1.07B | -34.19%2.74B | -131.73%-66M | -34.33%658M |
Net income continuous operations | -12.57%661M | -44.38%594M | -15.09%2.33B | 284.85%122M | -41.73%384M | -24.02%756M | -7.61%1.07B | -34.18%2.74B | -131.58%-66M | -34.17%659M |
Noncontrolling interests | -38.89%11M | 27.78%23M | -216.67%-42M | -9,300.00%-94M | 420.00%16M | 5.88%18M | -28.00%18M | -52.63%36M | 50.00%-1M | -117.86%-5M |
Net income attributable to the company | -12.04%650M | -45.71%569M | -12.38%2.37B | 433.85%217M | -44.58%368M | -24.51%739M | -7.17%1.05B | -33.83%2.71B | -130.95%-65M | -31.76%664M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -12.04%650M | -45.71%569M | -12.38%2.37B | 433.85%217M | -44.58%368M | -24.51%739M | -7.17%1.05B | -33.83%2.71B | -130.95%-65M | -31.76%664M |
Gross dividend payment | ||||||||||
Basic earnings per share | -11.93%21.56 | -45.81%18.87 | -12.36%78.67 | 434.42%7.19 | -44.56%12.18 | -24.61%24.48 | -7.10%34.82 | -33.94%89.77 | -131.07%-2.15 | -31.98%21.97 |
Diluted earnings per share | -11.94%21.54 | -45.82%18.84 | -12.37%78.57 | 433.95%7.18 | -44.58%12.16 | -24.60%24.46 | -7.11%34.77 | -33.93%89.66 | -131.07%-2.15 | -31.99%21.94 |
Dividend per share | 0.00%19 | 0 | 0.00%38 | 0.00%19 | 0 | 0.00%19 | 0 | 5.56%38 | 5.56%19 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |